National Health Investors, Inc. (NYSE:NHI) Receives Consensus Rating of “Moderate Buy” from Analysts

National Health Investors, Inc. (NYSE:NHI) has earned an average rating of “Moderate Buy” from the five ratings firms that are currently covering the stock, Marketbeat reports. Two equities research analysts have rated the stock with a hold recommendation and three have assigned a buy recommendation to the company. The average 1 year price target among brokers that have covered the stock in the last year is $76.60.

Separately, Truist Financial reduced their price objective on National Health Investors from $78.00 to $72.00 and set a “hold” rating for the company in a research report on Monday, December 23rd.

National Health Investors Stock Performance

NHI opened at $71.35 on Wednesday. The firm has a market capitalization of $3.24 billion, a P/E ratio of 24.52, a price-to-earnings-growth ratio of 4.42 and a beta of 1.06. The stock’s 50 day moving average price is $68.59 and its two-hundred day moving average price is $75.08. The company has a quick ratio of 10.29, a current ratio of 10.29 and a debt-to-equity ratio of 0.92. National Health Investors has a 12-month low of $56.70 and a 12-month high of $86.13.

National Health Investors (NYSE:NHI) last released its earnings results on Tuesday, February 25th. The real estate investment trust reported $1.13 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.10 by $0.03. National Health Investors had a return on equity of 10.11% and a net margin of 38.53%. On average, equities analysts forecast that National Health Investors will post 4.41 earnings per share for the current year.

Hedge Funds Weigh In On National Health Investors

Several hedge funds and other institutional investors have recently modified their holdings of NHI. Norges Bank bought a new position in shares of National Health Investors during the 4th quarter worth approximately $42,322,000. Millennium Management LLC lifted its position in shares of National Health Investors by 1,967.0% during the 4th quarter. Millennium Management LLC now owns 488,353 shares of the real estate investment trust’s stock worth $33,843,000 after buying an additional 464,727 shares during the period. Balyasny Asset Management L.P. bought a new position in shares of National Health Investors during the 4th quarter worth approximately $23,917,000. Marshall Wace LLP lifted its position in shares of National Health Investors by 161.6% during the 4th quarter. Marshall Wace LLP now owns 551,585 shares of the real estate investment trust’s stock worth $38,225,000 after buying an additional 340,712 shares during the period. Finally, Zimmer Partners LP bought a new position in shares of National Health Investors during the 3rd quarter worth approximately $25,218,000. Institutional investors own 62.51% of the company’s stock.

National Health Investors Company Profile

Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.